Introduction
Oligozoospermic men requiring intracytoplasmic sperm injection (ICSI) often carry sperm populations characterised by an increase in chromosomal aberrations and a compromised DNA integrity. A higher incidence of numerical [Palermo et al. 2000; Simpson and Lamb 2001; Van Steirteghem et al. 2002] and structural chromosomal aberrations have been associated in studies in the embryos resulting from ICSI.
The selection of sperm for ICSI is commonly done via the microscopic assessment of motility and morphology. Sperm classified as normal morphology are found to host chromosomal aberrations [Celik-Ozenci et al. 2004] . Disomic and diploid sperm have been found in all categories of morphological classification [Zavaczki et al. 2006] .
Hyaluronic acid (HA) is thought to be critical within the female reproductive tract when selecting functionally competent sperm during in vivo fertilization. The human oocyte is surrounded by the cumulus oophorus, whose major component is HA, a high molecular weight glycosaminoglycan. Developmentally mature sperm were found to bind to HA gels similarly to the binding between sperm and zona pellucida. The binding of sperm to HA in vitro is a selection process. In another study it has been demonstrated that there are exceptions when motile sperm do not bind to HA [Huszar et al. 2003 ].
Simultaneously with cytoplasmic extrusion in spermiogenesis, there is also a remodeling of the plasma membrane that facilitates the formation of the zona pellucida-and HAbinding sites [Huszar et al. 1997 [Huszar et al. , 2003 ]. HA-binding associated with the presence of the HA receptors on the sperm surface is related to sperm development [Huszar and Vigue 1993] . Sperm with HA-binding ability are viable having either intact or slightly capacitated acrosomal status and appear devoid of significant DNA degradation [Huszar et al. 2007; Yagci et al. 2010] .
Diminished expression of the heat shock-related 70 kDa protein 2 (HspA2), a testis-specific chaperone protein, part of the meiotic synaptonemal complex, causes meiotic defects leading to aneuploidies [Kovanci et al. 2001] . There is a relationship between diminished sperm development (associated with oligozoo/asthenozoo/teratozoospermia), low levels of HspA2 expression, increased frequency of chromosomal aneuploidies, the presence of apoptotic process, and fragmented DNA [Huszar and Vigue 1993; Huszar et al. 2000 Huszar et al. , 2003 Huszar et al. , 2007 Yagci et al., 2010] . In vitro solid-state HAbinding facilitates the selection of individual mature sperm with low levels of chromosomal aneuploidies [Jakab et al. 2005] . Based on the percentage of bound sperm, three binding zones were established: excellent (480%), moderate (60-80%), and low (560%). The HA sperm selection method for ICSI might reduce the potential genetic complications and adverse public health effects of ICSI [Jakab et al. 2005] .
In the present study we examined (1) the clinical success of ICSI with HA-selected sperm ('physiologic' ICSI, PICSI) compared to the conventional ICSI, (2) the necessity to differentiate patients according to the initial HA-binding assay result, and (3) whether the sperm concentration or the HA-binding ability can give more information about fertilization outcome. For this purpose, (i) we analyzed the clinical outcome (fertilization rate (FR), implantation rate (IR), clinical pregnancy rate (CPR), life birth rate (LBR), and pregnancy loss rate (PLR)) of 250 infertile couples (idiopathic infertile couples or infertility caused by male factor infertility) conceived by PICSI or ICSI, (ii) we carried out initial HAbinding score of all male partners, formed different groups according to the results, and then analyzed the clinical outcome, and finally (iii) we studied the correlation between the sperm concentration, HA-binding capacity, and fertilization rate.
Results

Clinical outcome of PICSI vs. ICSI
An average of 10.6 Metaphase II oocytes and 7.9 2PN zygotes were produced. The average fertilization rate was 62.7%. The male patients demonstrated average sperm concentration of 33.3 Â 10 6 /mL with 52.6% HBA score. In all cases the morphology of the embryos was normal (530% fragmentation; [WHO 2010]) . The results of Study 1 are summarized in Figure 1 .
In the ICSI group the average sperm concentration proved to be 39.2 Â 10 6 /mL, the HBA score 62.5%, the FR 56.5%, the IR 17.12%, the CPR 29.22%, the LBR 0.42%, and the PLR 5.14%, respectively. In the ICSI group, where the HBA score was 460%, the average sperm concentration was 47.4 Â 10 6 / mL, HBA score was 75.7%, FR was 60.14%, IR was 21.47%, CPR was 31.85%, LBR was 0.58%, and PLR was 8.37%. In the ICSI group with HBA score 60% the parameters found were as follows: average sperm concentration: 20.1 Â 10 6 /mL, the HBA score: 31.7%, the FR: 52.85%, the IR: 12.76%, the CPR: 26.6%, the LBR: 0.27%, and the PLR: 1.9%. 
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Fertilization rate (FR) of patients with HBA 460%, patients with HBA 60%, and all patients; (B) Implantation rate (IR) of patients with HBA460%, patients with HBA 60%, and all patients; (C) Clinical pregnancy rate (CPR) of patients with HBA 460%, patients with HBA 60%, and all patients; (D) Life birth rate (LBR) of patients with HBA 460%, patients with HBA 60%, and all patients; (E) Pregnancy loss rate (PLR) of patients with HBA 460%, patients with HBA 60%, and all patients. Statistical significance (*) is indicated at p50.05. HBA: hyaluronic acid (HA) binding ability;ICSI: intracytoplasmic sperm injection; PICSI: ICSI with HA-selected sperm ('physiologic' ICSI). In the PICSI group the average sperm concentration was 25.6 Â 10 6 /mL associating with HBA score of 34.8%; the FR was 64.5%; the IR 21.7%, the CPR 40.46%, the LBR 0.45%, and the PLR 2%. In the PICSI group, where the HBA score was 460%, the average sperm concentration was measured as 35.5 Â 10 6 /mL, the HBA score 66.7%, the FR 73.36%, the IR 20.8%, the CPR 41.67%, the LBR 0.42%, and the PLR 2.2%. In the PICSI group with HBA score 60% the same parameters are as follows: average sperm concentration: 24.8 Â 10 6 /mL, the HBA score: 32.3%, the FR: 55.7%, the IR: 22.6%, the CPR: 39.3%, the LBR: 0.49%, and the PLR: 1.99%.
The FR of the PICSI group with 460% HBA was significantly higher than that in the ICSI group with 460% HBA (p50.01). The IR of the PICSI group with 60% HBA proved to be significantly higher than that in the ICSI group with 60% (p50.001). The CPR was significantly higher in every PICSI group compared to the ICSI groups (p50.01). We have observed a significantly higher LBR in the PICSI group with 60% HBA compared to ICSI patients with the same HBA ratio ( 60%; p50.001). PLR was significanly lower in PICSI patients and in the PICSI group with above 60% HBA compared to the ICSI group and the ICSI patients with 460% HBA, respectively (p50.0001).
Characterization according to the HBA score
Patients were further differentiated into two groups: HAexcellent (470%) and HA-low bound sperm (550%) groups based upon their HA binding capacity (%). The ICSI group with excellent HBA consisted of 69 couples and the ICSI group with 550% HBA contained 32 patients. The PICSI group with excellent HBA consisted of six couples and the PICSI group with 550% HBA contained 87 patients. The results of Study 2 are summarized in Figure 2 .
In the ICSI group, where the HBA score was 470%, the average sperm concentration was 54.1 Â 10 6 /mL, the HBA score 84.1%, the FR 70.14%, the IR 21.5%, the CPR 35.8%, the LBR 0.58%, and the PLR 8.3%, respectively. In the ICSI group with 550% HBA the average sperm concentration proved to be 16.13 Â 10 6 /mL, the HBA score 24%, the FR 47.24%, the IR 12.5%, the CPR 30.8%, the LBR 0.26%, and the PLR 9.15%. In the PICSI group, where the HBA score was 470%, the average sperm concentration was 54.1 Â 10 6 /mL, the HBA score 83.1%, the FR 73.4%, the IR 20.8%, the CPR 41.7%, the LBR 0.4%, and the PLR 2.2%. In the PICSI group with 550% HBA the average sperm concentration was 24.1 Â 10 6 /mL, the HBA score 28.5%, the FR 55.42%, the IR 24.02%, the CPR 41.2%, the LBR 0.5%, and the PLR 4.65%.
The FR, IR, CPR, and LBR of the PICSI group with550% HBA were significantly higher and the PLR was significantly lower than those in the ICSI group with 550% HBA (p50.01). The PLR of the PICSI group with 470% HBA proved to be significantly lower than that in the ICSI group with 470% HBA (p50.0001).
Correlation analysis between sperm concentration, HA-binding capacity, and fertilization rate
The Pearson correlation (r) between the sperm concentration and HA-binding capacity was determined by comparing all samples in the ICSI and PICSI groups. The Pearson correlation between the sperm concentration and FR and between the HBA score and FR independent of treatment (ICSI or PICSI), were respectively calculated. The results of the correlation analysis are summarized in Figure 3 .
A statistically significant positive correlation was found between the sperm concentration and the HA-binding 
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patients with HBA 470% and patients with HBA 550%; (B) Implantation rate (IR) of patients with HBA 470% and patients with HBA 550%; (C) Clinical pregnancy rate (CPR) of patients with HBA 470% and patients with HBA 550%; (D) Life birth rate (LBR) of patients with HBA 470% and patients with HBA 550%; (E) Pregnancy loss rate (PLR) of patients with HBA 470% and patients with HBA 550%. Statistical significance (*) is indicated at p50.05. HBA: hyaluronic acid (HA) binding ability; ICSI: intracytoplasmic sperm injection; PICSI: ICSI with HA-selected sperm ('physiologic' ICSI). DOI: 10.3109/19396368.2014.948102 Is sperm hyaluronan binding predictive for clinical success of ICSI? 3 capacity (r ¼ 0.62, p50.001). We found a higher positive correlation between HBA score and FR (r ¼ 0.53, NS) than between sperm concentration and FR (r ¼ 0.14, NS), but the difference was not statistically significant. In the ICSI and in the PICSI groups a higher positive correlation between HBA score and FR (r ¼ 0.51 and r ¼ 0.49, NS) than between sperm concentration and FR (r ¼ 0.22 and r ¼ 0.19, NS) was observed. This association was not statistically significant.
Discussion
We compared conventional ICSI (n ¼ 140) to ICSI in which the spermatozoa were selected for their capacity to bind to HA (PICSI, n ¼ 110). We observed a significantly higher FR in the PICSI group with 460% initial HBA; IR of the PICSI group with 60% HBA, and CPR in every PICSI group compared to the ICSI groups (p50.01). We also observed a significantly higher LBR in the PICSI group with 60% HBA compared to ICSI of patients with 60% HBA (p50.001). PLR was significantly lower in PICSI patients compared to the same parameter in the ICSI group (p50.0001). When the outcome was assessed as a function of the HBA score, the FR, IR, CPR, and LBR of the PICSI group with 550% HBA were significantly higher and the PLR was significantly lower than in the ICSI group with 550% HBA (p50.01). A statistically significant positive correlation was found between the sperm concentration and the HA-binding capacity (r ¼ 0.62, p50.001). We found a closer relationship between HBA score and FR (r ¼ 0.53, NS) than between sperm concentration and FR (r ¼ 0.14, NS).
Previous studies regarding the development and function of biochemical and molecular markers of human sperm are supported by the above clinical results. A relationship between HA selected sperm and increased levels of developmental maturity [Cayli et al. 2004; Huszar et al. 1994 Huszar et al. , 2003 , as well as nuclear [Kovanci et al. 2001; Jakab et al. 2005] , and cytoplasmic integrity [Huszar et al. 1997; Sakkas et al. 1999] have been demonstrated.
A similar increase in IR, CPR, and lower PLR values was found by Worrilow and colleagues [Worrilow et al. 2006; Worrilow et al. 2007; Worrilow et al. 2012] . Others compared conventional sperm selection and the use of sperm selected from a liquid source of HA and an increased IR was found [Parmegiani et al. 2010] . The same positive trend was observed comparing polyvinylpyrrolidone-ICSI (n ¼ 110) and PICSI (n ¼ 92) treatments [Ménézo and Nicollet 2004] . Q2 In a study of 50 couples, a higher FR was observed when HAselected spermatozoa were injected into oocytes [NasrEsfahani et al. 2008] . These studies, in accordance with ours, did not demonstrate any negative effect on embryogenesis using HA sperm selection for ICSI, but they all was 'inhouse' developed HA slides.
In two further reports, no association was found between HA binding and FR, fragmentation, and embryo quality though they used washed sperm [Choe et al. 2012; Tarozzi et al. 2009 ]. In another report the clinical outcome of sperm functional assays including HBA was studied [Nijs et al. 2009] . A correlation of HA-binding was found with morphology, but it did not predict FR and CPR. Another recent study did not find any differences in FR, IR, and CPR between ICSI and PICSI patients. The only benefit of injecting HA selected sperm was a lower PLR which consequently translated to a higher LBR, both of which were not statistically significant [Majumdar and Majumdar 2013] .
No visual integrity of the DNA in selected sperm can be assessed which can basically determine the overall success of ICSI. When natural and assisted reproduction fails defects in sperm chromatin have been blamed [Bungum et al. 2007; Carrell et al. 2007 ]. Sperm DNA damage was found to be positively correlated with PLR when 11 studies involving 1,549 in vitro fertilization (IVF) and ICSI cycles was systematically reviewed [Zini et al. 2008] . It is well known that the proportion of immature sperm closely correlates with chromosomal disomies [Kovanci et al. 2001] . The relationship between the frequencies of chromosomal aneuploidies and diminished sperm maturity is thought to reflect that cytoplasmic retention and diminished maturity in sperm are associated with a low expression of the HspA2 [Eddy 1999; Huszar et al. 2000] . The relationship between sperm zona pellucida binding competence and maturity has been identified earlier. In the semen samples there were sperm with various degrees of cytoplasmic retention, but all sperm bound to the zona pellucida were mature as characterized with the absence of any cytoplasmic retention. Diminished HspA2 chaperone activity found in developmentally immature sperm is thought to be connected with a diminished presence of DNA repair enzymes, causing DNA chain breaks and fragmentation [Dix et al. 1996; Eddy 1999; Huszar et al. 2000] . There is a correlation between the decreased levels of expression of the HspA2 chaperone and sperm cellular development as well as IVF success [Ergur et al. 2002; Huszar et al. 1992 Huszar et al. , 2000 . Van Steirteghem et al. [2002] found increased rates of de novo numerical and cytogenetically detectable structural chromosomal aberrations following ICSI. The low concentration of HspA2 in the undeveloped spermatozoa likely suggests numerical chromosomal aberrations in sperm of oligozoospermic or severely oligozoospermic men [Huszar et al. 2007 ].
An enhancement of DNA and chromosomal integrity was demonstrated in HA-bound sperm by Yagci et al. [2010] when they analyzed HA-bound sperm with acridine orange fluorescence and they did not find DNA fragmentation. Selecting individual mature sperm with low levels of chromosomal disomy, diploidy, and sex chromosome disomy is facilitated by HA-binding and might reduce the potential genetic complications in male candidates for ICSI [Jakab et al. 2005] . It has been observed that almost all HA-bound spermatozoa are devoid of persistent histones, which correlated with DNA strand breakage [Sati et al. 2004] .
After ICSI, no sperm function tests were well correlated with FR. These results are in line with the data of several studies [Bakos et al. 2008; Henkel et al. 2003; Nasr-Esfahani et al. 2008 ] but contradictory to the data presented above, where we found PICSI proved to be significantly more effective than ICSI in respect of clinical success for patients with a low initial HBA score ( 50%). Based on our results HA selection becomes an important factor in cases with low binding scores, where the expected number of normal sperm is much lower. It has been observed in a single study where a correlation was found between sperm HA-binding capacity and FR after IVF [Pregl Breznik et al. 2013] . Our results indicate that sperm selection by HA binding is promising and significantly improves the success of the result in patients with a low HBA score. We conclude that HBA screening prior to ICSI may be useful to increase clinical success. It has been demonstrated that injection of spermatozoa recovered from HA-containing products had no negative effects on postinjection zygote development [Balaban et al. 2003; Barak et al. 2001] . A statistically significant reduction in PLR was observed in patients with a low HBA score. The use of HA sperm selection may be considered in patients with an initial HBA score of 50%. To determine the use of HA-bound sperm in ICSI, the use of HBA score would be beneficial since it could offer a balance to unnecessary treatment.
Materials and Methods
Patients
A total of 250 couples referred to the Assisted Reproduction Center, Kaali Institute, Medical and Health Science Center, University of Debrecen for ICSI were studied. The study was done between January 2012 and March 2013. In this period, 140 ICSI and 110 PICSI were carried out on the basis of the sperm HA-binding ability of the male partner (HBA score): when initial HBA score was 460% ICSI was carried out (n ¼ 98), in cases with HBA score 60% PICSI was performed (n ¼ 102). The ICSI group included 42 couples where the sperm number and the HBA score was low and unsuitable for PICSI. Q3 We carried out eight control PICSI where the HBA score was 460%.
Women under the age of 40 (mean: 33.18, range: 22-40) with regular (21-35 days) menstrual cycles, with normal baseline follicle stimulating hormone (FSH) level ( 12 IU/L) were eligible. Within the overall studied population the average male age was 35.8 years (range: 23-45). Patients excluded from the study were as follows: those from whom testicular sperm were taken, who got donor or cryopreserved gametes, received preimplantation genetic diagnosis, underwent sperm sorting procedures, patients whose maternal age was 440 years, and those who demonstrated a sperm count 510,000 motile sperm/mL.
Prior to the study, all patients were given detailed information about the aim and method of investigation and their consents were obtained. All protocols had to be approved by the author's respective Institutional Review Board (IRB) for human subjects (IRB reference number: 2976/2012-EHR).
Stimulation protocols
Standard stimulation protocols, gonadotropin releasing hormone (GnRH) agonist long (n ¼ 75), short (n ¼ 120), and GnRH antagonist (n ¼ 55), were used. The stimulation protocol and dose of gonadotropins were not standardized for the study; the decision was made by the physician.
For the long protocol, GnRH agonist was started in the midluteal phase. During suppression the dosage was reduced to half and stimulation with either recombinant FSH or human menopausal gonadotropin, or the combination of the two were DOI: 10.3109/19396368.2014.948102 Is sperm hyaluronan binding predictive for clinical success of ICSI? 5 used. For the short protocol, the GnRH agonist was started on cycle day 2 and gonadotropin stimulation was initiated on day 3. In the case of the antagonist protocol, stimulation was started on day 2 of the cycle and the GnRH antagonist was started when the largest follicles had reached 13-14 mm in size. When at least two follicles reached 17 mm in diameter, recombinant human chorionic gonadotropin (hCG) was used to trigger ovulation. Transvaginal oocyte retrieval was performed 35-36 h later.
Semen analysis and hyaloronic acid binding assay
Semen specimens were collected after a requested abstinence of two to three days on the day of the oocyte retrieval. The sperm sample was maintained at room temperature (18-28 C) for 30 to 60 min to allow it to liquefy. Semen analysis was performed manually according to WHO guidelines and morphology was examined using strict criteria [WHO 2010] . The HBA-test (hyaloronic acid binding assay) (MidAtlantic Diagnostics, Martlon, NJ, USA) was carried out at room temperature: the sample was mixed and a pipette of 7-10 ml was placed near the center of the chamber.
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The CELL-VU gridded cover slip was located over the chamber to avoid air bubble formation. The chamber was incubated at room temperature for at least 10 min, but not more than 20 min: this period proved to be necessary for sperm to bind to HA (according to the HBA-test protocol). The number of bound, motile sperm and the totality of motile sperm was scored. At least 200 spermatozoa in the same square or the entire 100 squares were counted. The ratio of hyaluronic binding motile sperm was calculated as follows:
Fertilization Gradient centrifugation (600 g for 10 min) was used to separate the cellular components of semen (PureCeptionÔ Sperm Washing Solution, SAGE, Pasadena, CA, USA). Following centrifugation the supernatant was removed and the sediment was washed twice (Quinn's Advantage Õ Sperm Washing Medium, SAGE, Pasadena, CA, USA; 600 g for 10 min). The supernatant was removed again and the sediment was diluted.
In order to select the morphologically 'best' spermatozoon, sperm were placed into standard ICSI dishes which were later injected into oocytes. We placed the final sperm suspension of PICSI patients upon microdots of hyaluronic acid in the PICSI Õ Sperm Selection Device (Biocoat, Inc., Horsham, PA, USA) and then overlaid it with oil (SAGE, Pasadena, CA, USA). After an incubation period of 5 to 10 min, HBA sperm were selected as per the manufacturer's instructions. We selected spermatozoa bound to HA in the junction zone of the two droplets and it was easy to detach then by an injecting pipette (ICSI Micropipette; ORIGIO, Charlottesville, VA, USA) and subsequently injected into oocytes.
Embryo culture
In the presence of two pronuclei fertilization was confirmed. The embryos were transferred to Quinn's Advantage Õ Protein
Plus Cleavage Medium at this stage (SAGE) and in microdroplets of 20-25 mL under Washed Oil for Tissue Culture, groups of 3-5 were cultured until the 6-8 cell stage (SAGE). After this, embryos were put to Q5 Quinn's Advantage Õ Protein Plus Blastocyst Medium (SAGE).
One, two, or three embryos were transferred following 3 or 5 d of fertilization. It was the couple's decision of how many embryos to be transferred after consulting with their physician. The morphology of the embryos was the basis for the transfer.
Statistical analysis
Statistical analyses were performed with commercial software SigmaStat and SPSS. Sample normality was assessed using Shapiro-Wilk test, sample homogeneity using Barlett test. Differences in the sperm concentration, HA-binding ability, FR, IR, CPR, LBR, and PLR between the ICSI and PICSI groups were analyzed using Mann-Whitney/Wilcoxon TwoSample Test, Kruskal-Wallis test (when normality does not exist), and Two-sample t-probe (when normality exists). A value of p50.05 was considered a significant difference. Correlation analyses between the sperm concentration, HA-binding capacity, and FR using all samples in the two groups were examined with Pearson correlation test.
It was the number of eggs fertilized with the given method that determined the fertilization rate (FR) for each patient. Implantation rate (IR) was calculated from the number of intrauterine sacs/the number of embryos transferred in each patient. There is an agreement that clinical pregnancy means that fetal cardiac activity is present within an intrauterine gestational sac. Vaginal ultrasound was used to assess pregnancy loss rate (PLR) and it means the proportion of patients demonstrating an intrauterine sac at 5-7 w of gestation and those where no fetal cardiac activity was present at 8-10 w of gestation.
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